Merrimack Pharmaceuticals
MACK
#8766
Rank
C$0.32 B
Marketcap
C$21.69
Share price
0.00%
Change (1 day)
5.31%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): C$18.74

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$19.87. In 2016 the company made an earnings per share (EPS) of C-$17.54 an increase over its 2015 EPS that were of C-$18.93.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C$18.74
2016C-$17.54-7.35%
2015C-$18.9365%
2014C-$11.47-39.39%
2013C-$18.93-54.01%
2012C-$41.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.84-85.71%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
C-$0.11-100.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
C-$2.71-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.20-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$42.00-311.33%๐Ÿ‡บ๐Ÿ‡ธ USA